Skip to main content
Top
Published in: Annals of Surgical Oncology 11/2019

01-10-2019 | Urothelial Cancer | Urologic Oncology

Long-Term Oncologic Outcomes of Laparoscopic Versus Open Radical Nephroureterectomy for Patients with T3N0M0 Upper Tract Urothelial Carcinoma: A Multicenter Cohort Study with Adjustment by Propensity Score Matching

Authors: Keisuke Shigeta, MD, Eiji Kikuchi, MD, PhD, Takayuki Abe, MD, PhD, Masayuki Hagiwara, MD, PhD, Koichiro Ogihara, MD, Tadanori Anno, MD, Kota Umeda, MD, Yuto Baba, MD, Tansei Sanjo, MD, Kazunori Shojo, MD, Ryuichi Mizuno, MD, PhD, Mototsugu Oya, MD, PhD

Published in: Annals of Surgical Oncology | Issue 11/2019

Login to get access

Abstract

Background

This study aimed to investigate the long-term oncologic outcomes of laparoscopic radical nephroureterectomy (LRNU) and open radical nephroureterectomy (ORNU) for patients with clinical and pathologic T3N0M0 upper tract urothelial carcinoma (UTUC).

Methods

Among 375 UTUC patients who underwent radical nephroureterectomy, this study identified 144 pT3N0M0 patients as cohort 1 after propensity score (PS) matching. Among 399 UTUC patients, the study identified 110 cT3N0M0 patients as cohort 2 after PS matching. Oncologic outcomes such as intravesical recurrence-free survival (IVRFS) and cancer-specific survival (CSS) were assessed by multivariate Cox’s regression analysis.

Results

Cohort 1 of pT3N0M0 UTUC had 3-year CSS and IVRFS rates of 67.9 and 52.7%, respectively, in the LRNU group, which were significantly lower than in the ORNU group (81.4%, p = 0.039 and 71.6%, p = 0.046). The multivariate Cox’s regression analysis identified the type of surgical approach (LRNU vs. ORNU) as one of the independent prognostic factors for CSS (hazard rate [HR], 1.88, p = 0.043) and IVRFS (HR, 1.75, p = 0.049). Cohort 2 of cT3N0M0 UTUC had 3-year CSS and IVRFS rates of 48.5 and 41.4%, respectively, in the LRNU group, which were significantly lower than in the ORNU group (65.8%, p = 0.049 and 67.2%, p = 0.047), and the type of surgical approach (LRNU vs. ORNU) remained as one of the independent prognostic factors for CSS and IVRFS.

Conclusions

Based on clinical and pathologic T3N0M0 UTUC populations after PS adjustments, LRNU resulted in poorer CSS and IVRFS than ORNU.
Appendix
Available only for authorised users
Literature
1.
go back to reference Roupret M, Babjuk M, Comperat E, et al. European Association of Urology guidelines on upper urinary tract urothelial carcinoma: 2017 update. Eur Urol. 2018;73:111–22.CrossRefPubMed Roupret M, Babjuk M, Comperat E, et al. European Association of Urology guidelines on upper urinary tract urothelial carcinoma: 2017 update. Eur Urol. 2018;73:111–22.CrossRefPubMed
2.
go back to reference Clayman RV, Kavoussi LR, Figenshau RS, Chandhoke PS, Albala DM. Laparoscopic nephroureterectomy: initial clinical case report. J Laparoendosc Surg. 1991;1:343–9.CrossRefPubMed Clayman RV, Kavoussi LR, Figenshau RS, Chandhoke PS, Albala DM. Laparoscopic nephroureterectomy: initial clinical case report. J Laparoendosc Surg. 1991;1:343–9.CrossRefPubMed
3.
go back to reference Hanna N, Sun M, Trinh QD, et al. Propensity-score-matched comparison of perioperative outcomes between open and laparoscopic nephroureterectomy: a national series. Eur Urol. 2012;61:715–21.CrossRefPubMed Hanna N, Sun M, Trinh QD, et al. Propensity-score-matched comparison of perioperative outcomes between open and laparoscopic nephroureterectomy: a national series. Eur Urol. 2012;61:715–21.CrossRefPubMed
4.
go back to reference Ni S, Tao W, Chen Q, et al. Laparoscopic versus open nephroureterectomy for the treatment of upper urinary tract urothelial carcinoma: a systematic review and cumulative analysis of comparative studies. Eur Urol. 2012;61:1142–53.CrossRefPubMed Ni S, Tao W, Chen Q, et al. Laparoscopic versus open nephroureterectomy for the treatment of upper urinary tract urothelial carcinoma: a systematic review and cumulative analysis of comparative studies. Eur Urol. 2012;61:1142–53.CrossRefPubMed
5.
go back to reference Simone G, Papalia R, Guaglianone S, et al. Laparoscopic versus open nephroureterectomy: perioperative and oncologic outcomes from a randomised prospective study. Eur Urol. 2009;56:520–6.CrossRefPubMed Simone G, Papalia R, Guaglianone S, et al. Laparoscopic versus open nephroureterectomy: perioperative and oncologic outcomes from a randomised prospective study. Eur Urol. 2009;56:520–6.CrossRefPubMed
6.
go back to reference Miyazaki J, Nishiyama H, Fujimoto H, et al. Laparoscopic versus open nephroureterectomy in muscle-invasive upper tract urothelial carcinoma: subanalysis of the Multi-Institutional National Database of the Japanese Urological Association. J Endourol. 2016;30:520–5.CrossRefPubMed Miyazaki J, Nishiyama H, Fujimoto H, et al. Laparoscopic versus open nephroureterectomy in muscle-invasive upper tract urothelial carcinoma: subanalysis of the Multi-Institutional National Database of the Japanese Urological Association. J Endourol. 2016;30:520–5.CrossRefPubMed
7.
go back to reference Fang Z, Li L, Wang X, et al. Total retroperitoneal laparoscopic nephroureterectomy with bladder-cuff resection for upper urinary tract transitional cell carcinoma. J Investig Surg. 2014;27:354–9.CrossRefPubMed Fang Z, Li L, Wang X, et al. Total retroperitoneal laparoscopic nephroureterectomy with bladder-cuff resection for upper urinary tract transitional cell carcinoma. J Investig Surg. 2014;27:354–9.CrossRefPubMed
8.
go back to reference Ito A, Shintaku I, Satoh M, et al. Prospective randomized phase II trial of a single early intravesical instillation of pirarubicin (THP) in the prevention of bladder recurrence after nephroureterectomy for upper urinary tract urothelial carcinoma: the THP Monotherapy Study Group Trial. J Clin Oncol. 2013;31:1422–7.CrossRefPubMed Ito A, Shintaku I, Satoh M, et al. Prospective randomized phase II trial of a single early intravesical instillation of pirarubicin (THP) in the prevention of bladder recurrence after nephroureterectomy for upper urinary tract urothelial carcinoma: the THP Monotherapy Study Group Trial. J Clin Oncol. 2013;31:1422–7.CrossRefPubMed
9.
go back to reference Cowan NC, Turney BW, Taylor NJ, McCarthy CL, Crew JP. Multidetector computed tomography urography for diagnosing upper urinary tract urothelial tumour. BJU Int. 2007;99:1363–70.CrossRefPubMed Cowan NC, Turney BW, Taylor NJ, McCarthy CL, Crew JP. Multidetector computed tomography urography for diagnosing upper urinary tract urothelial tumour. BJU Int. 2007;99:1363–70.CrossRefPubMed
10.
go back to reference Soukup V, Capoun O, Cohen D, et al. Prognostic performance and reproducibility of the 1973 and 2004/2016 World Health Organization grading classification systems in non-muscle-invasive bladder cancer: a European Association of Urology non-muscle-invasive bladder cancer guidelines panel systematic review. Eur Urol. 2017;72:801–13.CrossRefPubMed Soukup V, Capoun O, Cohen D, et al. Prognostic performance and reproducibility of the 1973 and 2004/2016 World Health Organization grading classification systems in non-muscle-invasive bladder cancer: a European Association of Urology non-muscle-invasive bladder cancer guidelines panel systematic review. Eur Urol. 2017;72:801–13.CrossRefPubMed
11.
go back to reference Kikuchi E, Margulis V, Karakiewicz PI, et al. Lymphovascular invasion predicts clinical outcomes in patients with node-negative upper tract urothelial carcinoma. J Clin Oncol. 2009;27:612–8.CrossRefPubMed Kikuchi E, Margulis V, Karakiewicz PI, et al. Lymphovascular invasion predicts clinical outcomes in patients with node-negative upper tract urothelial carcinoma. J Clin Oncol. 2009;27:612–8.CrossRefPubMed
12.
go back to reference D’Agostino RB Jr. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med. 1998;17:2265–81.CrossRefPubMed D’Agostino RB Jr. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med. 1998;17:2265–81.CrossRefPubMed
13.
go back to reference Kim HS, Ku JH, Jeong CW, Kwak C, Kim HH. Laparoscopic radical nephroureterectomy is associated with worse survival outcomes than open radical nephroureterectomy in patients with locally advanced upper tract urothelial carcinoma. World J Urol. 2016;34:859–69.CrossRefPubMed Kim HS, Ku JH, Jeong CW, Kwak C, Kim HH. Laparoscopic radical nephroureterectomy is associated with worse survival outcomes than open radical nephroureterectomy in patients with locally advanced upper tract urothelial carcinoma. World J Urol. 2016;34:859–69.CrossRefPubMed
14.
go back to reference Peyronnet B, Seisen T, Dominguez-Escrig JL, et al. Oncological outcomes of laparoscopic nephroureterectomy versus open radical nephroureterectomy for upper tract urothelial carcinoma: a European Association of Urology guidelines systematic review. Eur Urol Focus. 2019;5:205–23.CrossRefPubMed Peyronnet B, Seisen T, Dominguez-Escrig JL, et al. Oncological outcomes of laparoscopic nephroureterectomy versus open radical nephroureterectomy for upper tract urothelial carcinoma: a European Association of Urology guidelines systematic review. Eur Urol Focus. 2019;5:205–23.CrossRefPubMed
15.
go back to reference Nison L, Bozzini G, Roupret M, Traxer O, Colin P. Clinical, ureteroscopic, and photodynamic diagnosis of urothelial carcinomas of the upper tract: state-of-the art review for the yearly scientific report of the French National Association of Urology. Prog Urol. 2014;24:977–86.CrossRefPubMed Nison L, Bozzini G, Roupret M, Traxer O, Colin P. Clinical, ureteroscopic, and photodynamic diagnosis of urothelial carcinomas of the upper tract: state-of-the art review for the yearly scientific report of the French National Association of Urology. Prog Urol. 2014;24:977–86.CrossRefPubMed
16.
go back to reference Soria F, Shariat SF, Lerner SP, et al. Epidemiology, diagnosis, preoperative evaluation, and prognostic assessment of upper-tract urothelial carcinoma (UTUC). World J Urol. 2017;35:379–87.CrossRefPubMed Soria F, Shariat SF, Lerner SP, et al. Epidemiology, diagnosis, preoperative evaluation, and prognostic assessment of upper-tract urothelial carcinoma (UTUC). World J Urol. 2017;35:379–87.CrossRefPubMed
18.
go back to reference Rassweiler J, Tsivian A, Kumar AV, et al. Oncological safety of laparoscopic surgery for urological malignancy: experience with more than 1000 operations. J Urol. 2003;169:2072–5.CrossRefPubMed Rassweiler J, Tsivian A, Kumar AV, et al. Oncological safety of laparoscopic surgery for urological malignancy: experience with more than 1000 operations. J Urol. 2003;169:2072–5.CrossRefPubMed
19.
go back to reference Ehdaie B, Chromecki TF, Lee RK, et al. Obesity adversely impacts disease specific outcomes in patients with upper tract urothelial carcinoma. J Urol. 2011;186:66–72.CrossRefPubMedPubMedCentral Ehdaie B, Chromecki TF, Lee RK, et al. Obesity adversely impacts disease specific outcomes in patients with upper tract urothelial carcinoma. J Urol. 2011;186:66–72.CrossRefPubMedPubMedCentral
20.
go back to reference Seisen T, Shariat SF, Cussenot O, et al. Contemporary role of lymph node dissection at the time of radical nephroureterectomy for upper tract urothelial carcinoma. World J Urol. 2017;35:535–48.CrossRefPubMed Seisen T, Shariat SF, Cussenot O, et al. Contemporary role of lymph node dissection at the time of radical nephroureterectomy for upper tract urothelial carcinoma. World J Urol. 2017;35:535–48.CrossRefPubMed
21.
go back to reference Ito Y, Kikuchi E, Tanaka N, et al. Preoperative hydronephrosis grade independently predicts worse pathological outcomes in patients undergoing nephroureterectomy for upper tract urothelial carcinoma. J Urol. 2011;185:1621–6.CrossRefPubMed Ito Y, Kikuchi E, Tanaka N, et al. Preoperative hydronephrosis grade independently predicts worse pathological outcomes in patients undergoing nephroureterectomy for upper tract urothelial carcinoma. J Urol. 2011;185:1621–6.CrossRefPubMed
22.
go back to reference Hurel S, Roupret M, Seisen T, et al. Influence of preoperative factors on the oncologic outcome for upper urinary tract urothelial carcinoma after radical nephroureterectomy. World J Urol. 2015;33:335–41.CrossRefPubMed Hurel S, Roupret M, Seisen T, et al. Influence of preoperative factors on the oncologic outcome for upper urinary tract urothelial carcinoma after radical nephroureterectomy. World J Urol. 2015;33:335–41.CrossRefPubMed
23.
go back to reference Clements T, Messer JC, Terrell JD, et al. High-grade ureteroscopic biopsy is associated with advanced pathology of upper-tract urothelial carcinoma tumors at definitive surgical resection. J Endourol. 2012;26:398–402.CrossRefPubMed Clements T, Messer JC, Terrell JD, et al. High-grade ureteroscopic biopsy is associated with advanced pathology of upper-tract urothelial carcinoma tumors at definitive surgical resection. J Endourol. 2012;26:398–402.CrossRefPubMed
24.
go back to reference Seisen T, Granger B, Colin P, et al. A systematic review and meta-analysis of clinicopathologic factors linked to intravesical recurrence after radical nephroureterectomy to treat upper tract urothelial carcinoma. Eur Urol. 2015;67:1122–33.CrossRefPubMed Seisen T, Granger B, Colin P, et al. A systematic review and meta-analysis of clinicopathologic factors linked to intravesical recurrence after radical nephroureterectomy to treat upper tract urothelial carcinoma. Eur Urol. 2015;67:1122–33.CrossRefPubMed
25.
go back to reference Shigeta K, Kikuchi E, Hagiwara M, et al. The conditional survival with time of intravesical recurrence of upper tract urothelial carcinoma. J Urol. 2017;198:1278–85.CrossRefPubMed Shigeta K, Kikuchi E, Hagiwara M, et al. The conditional survival with time of intravesical recurrence of upper tract urothelial carcinoma. J Urol. 2017;198:1278–85.CrossRefPubMed
Metadata
Title
Long-Term Oncologic Outcomes of Laparoscopic Versus Open Radical Nephroureterectomy for Patients with T3N0M0 Upper Tract Urothelial Carcinoma: A Multicenter Cohort Study with Adjustment by Propensity Score Matching
Authors
Keisuke Shigeta, MD
Eiji Kikuchi, MD, PhD
Takayuki Abe, MD, PhD
Masayuki Hagiwara, MD, PhD
Koichiro Ogihara, MD
Tadanori Anno, MD
Kota Umeda, MD
Yuto Baba, MD
Tansei Sanjo, MD
Kazunori Shojo, MD
Ryuichi Mizuno, MD, PhD
Mototsugu Oya, MD, PhD
Publication date
01-10-2019
Publisher
Springer International Publishing
Published in
Annals of Surgical Oncology / Issue 11/2019
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-019-07623-1

Other articles of this Issue 11/2019

Annals of Surgical Oncology 11/2019 Go to the issue